Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users

Drug and Alcohol Dependence

Volumn 85, Issue 3, 2006, Pages 236-243

  Ríos Olivares, Eddy ^a   Vilá, Luis M ^b   Reyes, Juan C ^a   Rodríguez, José W ^a   Colón, J Héctor M ^a   Pagán, Nat O ^a   Marrero, Amalia ^a   Ríos Orraca, Zilka M ^a   Boukli, Nawal M ^a   Shapshak, Paul ^c   Robles, Rafaela R ^a  

^a Universidad Central del Caribe School of Medicine   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

"Speedball"; Cocaine; Cytokines; Hepatitis C; Heroin; Lymphocyte proliferation

Indexed keywords

COCAINE; CYTOKINE; DIAMORPHINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; CELL PROLIFERATION; COCAINE-RELATED DISORDERS; CYTOKINES; FEMALE; HEPATITIS B; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; TH1 CELLS; TH2 CELLS;

HEPATITIS C VIRUS;

EID: 33750589229     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2006.05.013     Document Type: Article

References (46)

1. Allen J.E., and Maizels R.M. The TH1-TH2 system: reliable paradigm or dangerous dogma?. Immunol. Today 18 (1997) 387-392
2. Alter M.J., and Moyer L.A. The importance of preventing Hepatitis C virus infection among injection drug users in the United States. J. Acquir. Immune Defic. Syndr. 18 (1998) 6-10
3. Amill A., Gómez L., Fernández D.M., Bangdiwala S.I., Ríos E., and Hunter R.F. Changing profiles of injecting drug users with AIDS in a Hispanic population. Addiction 99 (2004) 47-56
4. Bansal A.S., Bruce J., Hogan P.G., Prichard P., and Powell E.E. Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-γ is elevated in patients with Hepatitis C infection. Clin. Immunol. 84 (1997) 139-144
5. Barcelli W., Rizzardi G.P., Velati C., Borghi M.O., Fain C., Lazzarin A., and Meroni P.L. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users. AIDS 9 (1995) 691-694
6. Bayer B.M., Mulroney S.E., Hernández M.C., and Ding X.Z. Acute infusions of cocaine result in time and dose-dependent effects on lymphocyte responses and corticosterone secretion in rats. Immunopharmacol. Immunotoxicol. 29 (1995) 19-28
7. Chen N., Gao, and Field E.H. Prevention of TH1 response is critical for tolerance. Transplantation 61 (1996) 1076-1083
8. Chiappelli F., Frost P., Manfrini E., Lee P., Pham L., Garcia C., Daley S., Kung M., and Villanueva P. Cocaine blunts human CD4+ cell activation. Immunopharmacol. 28 3 (1994) 233-240
9. Colón J.I., Marchand A.M., Encarnación G., Rodríguez-Malavé M.T., and Ortiz-Santini M.R. The use of polyantigenic immunomodulator in the management of patients infected with human immunodeficiency virus (HIV). J. Immunol. Immunopharmacol. 10 4 (1990) 133
10. Di Francesco P., Marini S., Pica F., Favalli C., Tubaro E., and Garaci E. In vivo cocaine administration influences lymphokine production and humoral immune response. Immunol. Res. 11 (1992) 74-79
11. Fan X.G., Liu W.E., Li C.Z., Wang Z.C., Luo L.X., Tan D.M., Hu G.L., and Zhang Z. Circulating TH1 and TH2 cytokines in patients with Hepatitis C virus infection. Mediators Inflamm. 7 (1998) 295-297
12. Fecho K., Nelson C.J., and Lysle D.T. Phenotypic and fuctional. Immunopharmacol. Immonotoxicol. 46 (2000) 193-207
13. Fiorentino D.F., Bond M.W., and Mosmann T.R. Two types of mouse T helper cell IV. TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J. Exp. Med. 170 (1998) 2081-2095
14. Galeazzi B., Tufano A., Barbierato E., and Bortolotti F. Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver 15 (1995) 209-212
15. Gan H., Zhang L., Newton T., Chang S.L., Ling W., and Kermani V. Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects and decreases interferon-10 in cocaine-dependent subjects. Clin. Immunol. 89 (1998) 181-190
16. Gómez M., Fernández D., Otero J., Miranda S., and Hunter R.F. The shape of the HIV/AIDS epidemic in Puerto Rico. Panamerican J. Public Health 7 (2001) 337-382
17. Harber M., Sundstedt A., and Wraith D. The Role of Cytokines in Immunological Tolerance: Potential for Therapy (2000), Cambridge University Press (1-20, Expert Rev. Mol. Med. ISSN 1462-3994)
18. Hofmann S.R., Ettinger R., Zhou Y.J., Gadina M., Lipsky P., Siegel R., Candotti F., and O'Shea J.J. Cytokines and their role in lymphoid development, differentiation and homeostasis. Curr. Opin. Allergy Clin. Immunol. 2 (2002) 495-506
19. Kelso A. TH1 and TH2 subsets: paradigms lost?. Immunol. Today 16 (1995) 374-379
20. Khaled A.R., Bulavin D.V., Kittipatarin C., Li W.Q., Alvarez M., Kim K., Young H.A., Fornace A.J., and Durum S.K. Cytokine-driven cell cycling is mediated through Cdc25A. J. Cell. Biol. 169 (2005) 755-763
21. Lafaille J.J. The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9 (1998) 139-151
22. Lydyard P., and Grossi C. Cells involved in the immune response. In: Roitt I., Brostoff J., and Male D. (Eds). Immunology (1998), Mosby, London 20
23. McCoy C.B., Metsch L.R., Collado-Mesa F., Arheart K.L., Messiah S.E., Katz D., and Shapshak P. The prevalence of HIV-1 and HCV among injection drug users who use high risk inner-city locales in Miami, Florida. Mem Inst Oswaldo Cruz, Rio de Janeiro 99 (2004) 789-793
24. Martin J.C., Castilla J., López M., Rocio A., González-Lahoz J., and Soriano V. Impact of chronic Hepatitis C on HIV-1 disease progression. HIV Clin. Trials 5 (2004) 125-131
25. Mayor A.A., Gómez M.A., Fernández D.M., Ríos-Olivares E., Thomas J.C., and Hunter R.F. Morbidity and mortality profile of HIV infected patients, with and without Hepatitis C coinfection. Am. J. Trop. Med. Hyg. 74 2 (2005) 239-245
26. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136 (1986) 2348-2357
27. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns secretion lead to different functional properties. Annu. Rev. Immunol. 7 (1989) 145-173
28. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: TH1, TH2 and more. Immunol. Today 17 (1996) 138-146
29. Napoli J., Bishop G.A., McGuinness P.H., Painter D.M., and McCaughan G.W. Progressive liver injury in chronic Hepatitis C infection correlates with increased intrahepatic expression of TH1-associated cytokines. Hepatology 24 (1996) 759-765
30. National Institute of Allergy and Infectious Disease, 2004. HIV/AIDS Statistics, NIAID Fact Sheet. U.S. Department of Health and Human Services 1-2.
31. Naumova T.A., Panchenko L.F., Pirozhkow S.V., Baronets V.Iu., and Aliab'eva T.N. Disorders in the immune status and hepatic pathologies in young heroin addicts. Vestn Ross. Akad. Nauk 3 (2003) 32-36
32. Pellegrino T.C., Dunn K.L., and Bayer B.M. Mechanisms of cocaine-induced decreases in immune cell function. Int. Immunopharmacol. 1 (2001) 665-675
33. Puerto Rico Health Department Surveillance Report, 9/30/2005, Casos de SIDA Confirmados en Puerto Rico hasta, pp. 1-5.
34. Ríos-Olivares E., Yamamura Y., Gómez M.A., Guzmán L., Rodríguez N., Fernández D., and Hunter-Mellado R.F. HCV genotype analysis in HCV-HIV-coinfected Puerto Ricans who are injecting drug users: undetermined and mixed infections. Cell. Mol. Biol. 47 (2001) 1017-1024
35. Rios Z., Rios-Olivares E., Garcia M.I., De Leon C., Guzman L.M., Rodríguez W., Romero D., and Hunter R. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells. Cell. Mol. Biol. 41 Suppl. I (1995) S93-S101
36. Robles R.R., Colón H.M., and Freeman D.H. Copping areas as sampling and recruitment sites for out-of-treatment crack and injection drug users. Drugs Society 7 (1993) 91-105
37. Sakaguchi E., Kozo K., Segawa M., Okamoto M., Sakaida I., and Okita K. TH1 down-regulation at the single-lymphocyte level in HCV-related liver cirrhosis and the effect of TGF-β on TH1 response: possible implications for the development of hepatoma. Hepatol. Res. 24 (2002) 282-289
38. Sundstedt A., Hoiden I., Rosendahl A., Kalland T., Van Rooijen N., and Dohlsten M. Immunoregulatory role of IL-10 during superantigen-induce hyporesponsiveness in vivo. J. Immunol. 158 (1997) 180-186
39. The Dogwood Center. Diseases and Death Associated with Injecting Drug Use Each Year in the United States (2004), The Dogwood Center, Princeton, NJ, USA pp. 1-2
40. Thornton A.M., and Shevach E.M. CD25+CD4+ Immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibing interleukin 2 production. J. Exp. Med. 188 (1998) 287-296
41. Van Ameijden E.J., Langendam M.W., Notenboom J., and Coutinho R.A. Continuing injecting risk behavior: results from the Amsterdam cohort study of drug users. Addiction 94 (1999) 1051-1061
42. Vila L., Ríos-Olivares E., Vila S., Ríos Z., Rivera E., Robles R., Reyes J.C., and Castillo X. Correlation of the suppressive activity of a biological response modifier on the proliferation of peripheral blood mononuclear cells and the reduction of HIV titer. Cell. Mol. Biol. 43 (1997) 981-988
43. Wang Y., Huang D.S., and Watson R.R. In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci. 54 (1994) 401-411
44. West J.P., Dykstra L.A., and Lysle D.T. Differential tolerance to morphine's immunomodulatory effects following continuous administration. Drug Alcohol Depend. 53 (1998) 31-38
45. Xu W., Flick T., Mitchel J., Knowles C., and Ault K. Cocaine effect on immunocompetent cells: an observation of in vitro cocaine exposure. Int. Immunopharmacol. 21 (1999) 463-472
46. Yamaoka K., Min B., Zhou Y., Paul W.E., and O'Shea J.J. Jak3 negatively regulates dendritic cell cytokine production and survival. Blood 106 9 (2005) 3227-3233